AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
EFFECTS OF APROTININ ON COAGULATION AND FIBRINOLYSIS ENZYMES
Authors: ESPANA F ESTELLES A AZNAR J
Citation: F. Espana et al., EFFECTS OF APROTININ ON COAGULATION AND FIBRINOLYSIS ENZYMES, FIBRINOLYSIS & PROTEOLYSIS, 12(2), 1998, pp. 119-119
DETAILED LOCALIZATION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR MESSENGER-RNA EXPRESSION AND ANTIGEN IN ATHEROSCLEROTIC PLAQUE ON HUMAN CORONARY-ARTERY
Authors: GRANCHA S ESTELLES A FALCO C CHIRIVELLA N ESPANA F AZNAR J
Citation: S. Grancha et al., DETAILED LOCALIZATION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR MESSENGER-RNA EXPRESSION AND ANTIGEN IN ATHEROSCLEROTIC PLAQUE ON HUMAN CORONARY-ARTERY, FIBRINOLYSIS & PROTEOLYSIS, 12(1), 1998, pp. 53-60
ALPHA(2)-MACROGLOBULIN AND C1-INACTIVATOR ARE PLASMA INHIBITORS OF HUMAN GLANDULAR KALLIKREIN (HK2)
Authors: HEEB MJ ESPANA F
Citation: Mj. Heeb et F. Espana, ALPHA(2)-MACROGLOBULIN AND C1-INACTIVATOR ARE PLASMA INHIBITORS OF HUMAN GLANDULAR KALLIKREIN (HK2), Blood cells, molecules, & diseases (Print), 24(19), 1998, pp. 411-418
LONGITUDINAL EVALUATION OF THE COMPLEXED-TO-TOTAL PROSTATE-SPECIFIC ANTIGEN RATIO IN MEN WITH PROSTATE DISEASE - EFFECT OF TREATMENT
Authors: ESPANA F MARTINEZ M ROYO M VERA CD ESTELLES A AZNAR J JIMENEZCRUZ JF
Citation: F. Espana et al., LONGITUDINAL EVALUATION OF THE COMPLEXED-TO-TOTAL PROSTATE-SPECIFIC ANTIGEN RATIO IN MEN WITH PROSTATE DISEASE - EFFECT OF TREATMENT, European journal of cancer, 34(9), 1998, pp. 1375-1380
MARKERS OF COAGULATION AND PLATELET ACTIVATION DURING PERCUTANEOUS MITRAL VALVULOPLASTY
Authors: FERNANDEZ MA VILLA P ESPANA F AZNAR J DEARELLANO AR CEBOLLA R
Citation: Ma. Fernandez et al., MARKERS OF COAGULATION AND PLATELET ACTIVATION DURING PERCUTANEOUS MITRAL VALVULOPLASTY, Blood coagulation & fibrinolysis, 9(7), 1998, pp. 581-585
INFLUENCE OF LIPOPROTEIN (A) LEVELS AND ISOFORMS ON FIBRINOLYTIC-ACTIVITY - STUDY IN FAMILIES WITH HIGH LIPOPROTEIN (A) LEVELS
Authors: FALCO C ESTELLES A DALMAU J ESPANA F AZNAR J
Citation: C. Falco et al., INFLUENCE OF LIPOPROTEIN (A) LEVELS AND ISOFORMS ON FIBRINOLYTIC-ACTIVITY - STUDY IN FAMILIES WITH HIGH LIPOPROTEIN (A) LEVELS, Thrombosis and haemostasis, 79(4), 1998, pp. 818-823
ABNORMAL EXPRESSION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE FACTOR IN SEVERE PREECLAMPSIA
Authors: ESTELLES A GILABERT J GRANCHA S YAMAMOTO K THINNES T ESPANA F AZNAR J LOSKUTOFF DJ
Citation: A. Estelles et al., ABNORMAL EXPRESSION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE FACTOR IN SEVERE PREECLAMPSIA, Thrombosis and haemostasis, 79(3), 1998, pp. 500-508
FREE AND COMPLEXED PROSTATE-SPECIFIC ANTIGEN IN THE DIFFERENTIATION OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE-CANCER - STUDIES IN SERUM AND PLASMA SAMPLES
Authors: ESPANA F ROYO M MARTINEZ M ENGUIDANOS MJ VERA CD ESTELLES A AZNAR J JIMENEZCRUZ JF HEEB MJ
Citation: F. Espana et al., FREE AND COMPLEXED PROSTATE-SPECIFIC ANTIGEN IN THE DIFFERENTIATION OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE-CANCER - STUDIES IN SERUM AND PLASMA SAMPLES, The Journal of urology, 160(6), 1998, pp. 2081-2088
VAPOR-LIQUID-EQUILIBRIA FOR THE BINARY-SYSTEMS OF METHYLCYCLOHEXANE WITH 1-PROPANOL, 2-PROPANOL, 1-BUTANOL, AND 2-BUTANOL AT 101.3 KPA (VOL42, PG 914, 1997)
Authors: LORAS S MONTON JB ESPANA F
Citation: S. Loras et al., VAPOR-LIQUID-EQUILIBRIA FOR THE BINARY-SYSTEMS OF METHYLCYCLOHEXANE WITH 1-PROPANOL, 2-PROPANOL, 1-BUTANOL, AND 2-BUTANOL AT 101.3 KPA (VOL42, PG 914, 1997), Journal of chemical and engineering data, 43(1), 1998, pp. 121-121
HEMOSTATIC CHANGES IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS DURING ALL-TRANS-RETINOIC ACID (ATRA) THERAPY
Authors: GARCIA MC ROYO M MARCO P ROLDAN V FERNANDEZ P ESPANA F
Citation: Mc. Garcia et al., HEMOSTATIC CHANGES IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS DURING ALL-TRANS-RETINOIC ACID (ATRA) THERAPY, Thrombosis and haemostasis, 1997, pp. 512-512
INFLUENCE OF THE LEVELS AND ISOFORMS OF LIPOPROTEIN (A) [LP(A)] ON FIBRINOLYTIC-ACTIVITY - STUDY IN FAMILIES WITH HIGH LP(A) LEVELS
Authors: FALCO C ESTELLES A DALMAU J ESPANA F AZNAR J
Citation: C. Falco et al., INFLUENCE OF THE LEVELS AND ISOFORMS OF LIPOPROTEIN (A) [LP(A)] ON FIBRINOLYTIC-ACTIVITY - STUDY IN FAMILIES WITH HIGH LP(A) LEVELS, Thrombosis and haemostasis, 1997, pp. 621-621
PHENOTYPIC RESISTANCE TO ACTIVATED PROTEIN-C IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
Authors: AZNAR J VILLA P ESPANA F ESTELLES A GRANCHA S FALCO C
Citation: J. Aznar et al., PHENOTYPIC RESISTANCE TO ACTIVATED PROTEIN-C IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES, Thrombosis and haemostasis, 1997, pp. 1307-1307
ALTERED EXPRESSION OF PAI-2 MESSENGER-RNA IN PLACENTAS FROM PREGNANCIES COMPLICATED WITH INTRAUTERINE FETAL GROWTH-RETARDATION (IUGR)
Authors: GRANCHA S ESTELLES A GILABERT J CHIRIVELLA M ESPANA F AZNAR J
Citation: S. Grancha et al., ALTERED EXPRESSION OF PAI-2 MESSENGER-RNA IN PLACENTAS FROM PREGNANCIES COMPLICATED WITH INTRAUTERINE FETAL GROWTH-RETARDATION (IUGR), Thrombosis and haemostasis, 1997, pp. 1454-1454
REDUCED LEVELS OF CIRCULATING ACTIVATED PROTEIN-C IN PATIENTS WITH MYOCARDIAL-INFARCTION
Authors: ROYO M ESPANA F FERNANDEZ P MARCO P ESTELLES A AZNAR J
Citation: M. Royo et al., REDUCED LEVELS OF CIRCULATING ACTIVATED PROTEIN-C IN PATIENTS WITH MYOCARDIAL-INFARCTION, Thrombosis and haemostasis, 1997, pp. 1703-1703
FIBRINOLYSIS AND LIPOPROTEIN (A) [LP(A)] IN CORONARY-ARTERY DISEASE (CAD) - INFLUENCE OF POSTMENOPAUSAL STATUS AND HORMONE REPLACEMENT THERAPY (HRT)
Authors: ESTELLES A TORMO G GILABERT J FALCO C ESPANA F RODRIGUEZ J TORMO V AZNAR J
Citation: A. Estelles et al., FIBRINOLYSIS AND LIPOPROTEIN (A) [LP(A)] IN CORONARY-ARTERY DISEASE (CAD) - INFLUENCE OF POSTMENOPAUSAL STATUS AND HORMONE REPLACEMENT THERAPY (HRT), Thrombosis and haemostasis, 1997, pp. 2118-2118
REFERENCE RANGES FOR THE CONCENTRATIONS OF TOTAL AND COMPLEXED PLASMAPROSTATE-SPECIFIC ANTIGEN AND THEIR RATIO IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIA
Authors: ESPANA F MARTINEZ M ROYO M VERA CD ESTELLES A AZNAR J JIMENEZCRUZ JF
Citation: F. Espana et al., REFERENCE RANGES FOR THE CONCENTRATIONS OF TOTAL AND COMPLEXED PLASMAPROSTATE-SPECIFIC ANTIGEN AND THEIR RATIO IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIA, European urology, 32(3), 1997, pp. 268-272
ACTIVATED PROTEIN-C RESISTANCE PHENOTYPE IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
Authors: AZNAR J VILLA P ESPANA F ESTELLES A GRANCHA S FALCO C
Citation: J. Aznar et al., ACTIVATED PROTEIN-C RESISTANCE PHENOTYPE IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES, The Journal of laboratory and clinical medicine, 130(2), 1997, pp. 202-208
VAPOR-LIQUID-EQUILIBRIA FOR THE BINARY-SYSTEMS OF METHYLCYCLOHEXANE WITH 1-PROPANOL, 2-PROPANOL, 1-BUTANOL, AND 2-BUTANOL AT 101.3 KPA
Authors: LORAS S MONTON JB ESPANA F
Citation: S. Loras et al., VAPOR-LIQUID-EQUILIBRIA FOR THE BINARY-SYSTEMS OF METHYLCYCLOHEXANE WITH 1-PROPANOL, 2-PROPANOL, 1-BUTANOL, AND 2-BUTANOL AT 101.3 KPA, Journal of chemical and engineering data, 42(5), 1997, pp. 914-918
HEPARIN STIMULATION OF THE INHIBITION OF ACTIVATED PROTEIN-C AND OTHER ENZYMES BY HUMAN PROTEIN-C INHIBITOR - INFLUENCE OF THE MOLECULAR-WEIGHT OF HEPARIN AND IONIC-STRENGTH
Authors: AZNAR J ESPANA F ESTELLES A ROYO M
Citation: J. Aznar et al., HEPARIN STIMULATION OF THE INHIBITION OF ACTIVATED PROTEIN-C AND OTHER ENZYMES BY HUMAN PROTEIN-C INHIBITOR - INFLUENCE OF THE MOLECULAR-WEIGHT OF HEPARIN AND IONIC-STRENGTH, Thrombosis and haemostasis, 76(6), 1996, pp. 983-988
DECREASED EXPRESSION OF PAI-2 MESSENGER-RNA AND PROTEIN IN PREGNANCIES COMPLICATED WITH INTRAUTERINE PETAL GROWTH-RETARDATION
Authors: GRANCHA S ESTELLES A GILABERT J CHIRIVELLA M ESPANA F AZNAR J
Citation: S. Grancha et al., DECREASED EXPRESSION OF PAI-2 MESSENGER-RNA AND PROTEIN IN PREGNANCIES COMPLICATED WITH INTRAUTERINE PETAL GROWTH-RETARDATION, Thrombosis and haemostasis, 76(5), 1996, pp. 761-767
QUANTIFICATION OF CIRCULATING ACTIVATED PROTEIN-C IN HUMAN PLASMA BY IMMUNOASSAYS - ENZYME LEVELS ARE PROPORTIONAL TO TOTAL PROTEIN-C LEVELS
Authors: ESPANA F ZUAZU I VICENTE V ESTELLES A MARCO P AZNAR J
Citation: F. Espana et al., QUANTIFICATION OF CIRCULATING ACTIVATED PROTEIN-C IN HUMAN PLASMA BY IMMUNOASSAYS - ENZYME LEVELS ARE PROPORTIONAL TO TOTAL PROTEIN-C LEVELS, Thrombosis and haemostasis, 75(1), 1996, pp. 56-61
PROSTATE-SPECIFIC ANTIGEN AND ITS COMPLEXES WITH ALPHA(1)-ANTICHYMOTRYPSIN IN THE PLASMA OF PATIENTS WITH PROSTATIC DISEASE
Authors: ESPANA F MARTINEZ M SANCHEZCUENCA J VERA CD ESTELLES A JIMENEZCRUZ JF
Citation: F. Espana et al., PROSTATE-SPECIFIC ANTIGEN AND ITS COMPLEXES WITH ALPHA(1)-ANTICHYMOTRYPSIN IN THE PLASMA OF PATIENTS WITH PROSTATIC DISEASE, European urology, 30(4), 1996, pp. 512-518
QUANTITATIVE IMMUNOASSAY FOR COMPLEXES OF PROSTATE-SPECIFIC ANTIGEN WITH ALPHA(2)-MACROGLOBULIN
Authors: ESPANA F SANCHEZCUENCA J ESTELLES A GILABERT J GRIFFIN JH HEEB MJ
Citation: F. Espana et al., QUANTITATIVE IMMUNOASSAY FOR COMPLEXES OF PROSTATE-SPECIFIC ANTIGEN WITH ALPHA(2)-MACROGLOBULIN, Clinical chemistry, 42(4), 1996, pp. 545-550
ABNORMAL EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITORS IN PATIENTS WITH GESTATIONAL TROPHOBLASTIC DISEASE
Authors: ESTELLES A GRANCHA S GILABERT J THINNES T CHIRIVELLA M ESPANA F AZNAR J LOSKUTOFF DJ
Citation: A. Estelles et al., ABNORMAL EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITORS IN PATIENTS WITH GESTATIONAL TROPHOBLASTIC DISEASE, The American journal of pathology, 149(4), 1996, pp. 1229-1239
PROSTATE-SPECIFIC ANTIGEN-ALPHA(2)-MACROGLOBULIN COMPLEXES IN PROSTATE-CANCER PATIENT SERA
Authors: HEEB MJ ESPANA F GITTES RF GRIFFIN JH
Citation: Mj. Heeb et al., PROSTATE-SPECIFIC ANTIGEN-ALPHA(2)-MACROGLOBULIN COMPLEXES IN PROSTATE-CANCER PATIENT SERA, Biochemistry and molecular biology international, 37(5), 1995, pp. 917-923
Risultati: 1-25 | 26-45